SS Innovations reported FY 2025 total revenue of USD 42.48 million, up 106%, driven by higher sales of surgical robotic systems and instruments. Gross profit rose 131% to USD 19.54 million, while loss from operations narrowed 57% to USD 8.19 million. Net loss narrowed 37% to USD 12.13 million as gross profit increased and stock-based compensation expense fell, partly offset by higher R&D, depreciation, SG&A, and income tax expense. Cash at year-end was USD 9.6 million, and net cash used in operating activities was USD 18.54 million. On the balance sheet, total assets were USD 74.23 million and total stockholders’ equity was USD 38.22 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SS Innovations International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-025440), on March 10, 2026, and is solely responsible for the information contained therein.